Canadian Rheumatologists will be randomized to treat their participants with active Psoriatic Arthritis to a target (disease activity score <2.6), or as per their routine care. The aim of this study is to determine whether treating to a target results in greater disease improvement than treating patients using routine care.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01692912?cond=%22Arthritis%22&lup_s=10/31/2013&lup_d=30
